Stay updated with breaking news from True Human. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of XBiotech (NASDAQ:XBIT – Free Report) in a research report released on Thursday. The firm issued a sell rating on the biopharmaceutical company’s stock. XBiotech Stock Performance Shares of XBiotech stock opened at $5.90 on Thursday. XBiotech has a 52-week low of $3.05 and a 52-week high of $6.69. The […]
StockNews.com assumed coverage on shares of XBiotech (NASDAQ:XBIT – Free Report) in a research note published on Tuesday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. XBiotech Stock Up 17.3 % Shares of XBiotech stock opened at $5.43 on Tuesday. XBiotech has a 12 month low of $3.05 and a 12 month […]
StockNews.com started coverage on shares of XBiotech (NASDAQ:XBIT – Free Report) in a report published on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. XBiotech Price Performance XBiotech stock opened at $4.22 on Monday. The firm has a fifty day simple moving average of $4.19 and a two-hundred day simple moving […]
Acasti Pharma (NASDAQ:ACST – Get Free Report) and XBiotech (NASDAQ:XBIT – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership. Profitability This table compares Acasti Pharma and XBiotech’s […]
AUSTIN, Texas, Jan. 04, 2024 -- XBiotech Inc. today announced that it plans to expand it’s campus headquarters with the construction of a new, state-of-the-art research and development facility....